Suchergebnisse - "Liang, Yuh-Jin"

PubPharm (37)

1

Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122

enthalten in: Journal of medical virology | 2023

von Liang, Y. | Chiou, Y. | Chiu, A. | +10

2

Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122

enthalten in: Journal of Medical Virology | 2023

von Liang, Y. | Chiou, Y. | Chiu, A. | +10

3

Gene coexpression network analysis identifies hubs in hepatitis B virus-associated hepatocellular carcinoma

enthalten in: Journal of the Chinese Medical Association : JCMA | 2022

von Wang, S. | Huang, Y. | Liang, Y. | +1

4

Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions

enthalten in: Glycoconjugate journal | 2022

von Liang, Y.

5

Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions

enthalten in: Glycoconjugate journal | 2022

von Liang, Y.

6

Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions

enthalten in: Glycoconjugate journal | 2022

von Liang, Y.

7

Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions

enthalten in: Glycoconjugate journal | 2022

von Liang, Y.

8

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance

enthalten in: Cells | 2022

von Chang, Y. | Su, C. | Chen, S. | +3

9

Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Liang, Y. | Teng, W. | Chen, C. | +9

10

Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development

enthalten in: Hepatology | 2021

von Liang, Y. | Teng, W. | Chen, C. | +9